Service d'Anesthésie et Réanimation chirurgicale - CHU de Strasbourg - France
Strasbourg, 67091, France
NCT Number: NCT05185479
The interest of health databases in anesthesia is no longer to be demonstrated. The aim of this research was to develop a natural language processing approach to establish a classification of adverse events observed during the perioperative period and to facilitate their analysis:
The main objective of the study was to identify what a "naïve" unsupervised model would discover based on Adverse Event (AE) descriptions. Our second goal was to identify apparently unrelated events whose combination could favor the occurrence of an AE
Looking for future studies?
Notify Me1 year and older
All sexes
Observational
Strasbourg, 67091, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Files analysed retrospectively from January 01, 2009 to June 30, 2020 will be examined]
The aim of this research was to develop a natural language processing approach to establish a classification of adverse events observed during the perioperative period and to facilitate their analysis:
The main objective of the study was to identify what a "naïve" unsupervised model would discover based on Adverse Event (AE) descriptions. Our second goal was to identify apparently unrelated events whose combination could favor the occurrence of an AE
University Hospital, Strasbourg, France
Other
Acronym: ADVENTURE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07703982
Allergic Reaction, Hypersensitivity
Birmingham, Alabama, United States
View Trial DetailsNCT06011603
Allergic Reaction, Hypersensitivity
Chicago, Illinois, United States
View Trial DetailsNCT06957496
Allergic Reaction, Allergic Skin Reaction
Madrid, Spain
View Trial DetailsNCT06527937
Allergic Reaction, Hypersensitivity
Secaucus, New Jersey, United States
View Trial Details